CHRISTOPHER GREENHAGEN: Open Payments
NPI 1356764195 · NEWKIRK, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 38 payments from 10 companies in 2025. Trend: 2023 $16 · 2024 $59 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $204 |
| AstraZeneca Pharmaceuticals LP | 7 | $175 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Lundbeck LLC | 2 | $49 |
| Lilly USA, LLC | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Viatris Specialty LLC | 1 | $16 |
| Organon LLC | 1 | $7 |
Products named: BREZTRI, VRAYLAR, TRELEGY ELLIPTA, CAPLYTA, QULIPTA, REXULTI, AIRSUPRA, UBRELVY.
Industry payments across OK — which companies pay providers there.
